CHRISTOPHER MANUEL: Open Payments
NPI 1801110127 · KAPLAN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$93,975 in 110 payments from 2 companies in 2025. Trend: 2023 $283 · 2024 $50,315 · 2025 $93,975
Speaker / faculty: $71,630Travel & lodging: $15,205Consulting: $5,438Food & beverage: $1,702
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 101 | $93,719 |
| ACADIA Pharmaceuticals Inc | 9 | $256 |
Products named: INGREZZA, NUPLAZID.
Industry payments across LA — which companies pay providers there.
